Pneumology - Original Articles

Nicotine dependence and physical function: a comparison between current smokers with and without chronic obstructive pulmonary disease who seek cognitive-behavioral therapy

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 12 October 2026
Accepted: 21 October 2026
Published: 22 October 2026
36
Views
4
Downloads

Authors

Smoking is a chronic disease characterized by nicotine dependence that affects the physical and mental health of millions of people worldwide. This study compared the degree of nicotine dependence, general fatigue, lung function, functional exercise capacity (FEC), and quality of life (QoL) in smokers with and without chronic obstructive pulmonary disease (COPD) who were seeking cognitive-behavioral therapy (CBT). This cross-sectional study involved 53 smokers (27 in the COPD group and 26 in the noCOPD group). Participants underwent a FEC assessment using the Glittre-ADL test (TGlittre), as well as pulmonary function analysis via spirometry and impulse oscillometry (IOS) to detect small airway disease (SAD). Participants also completed the following assessments: the Fagerström test for nicotine dependence (FTND), the Richmond test for motivation to quit smoking, the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) scale, and the Short Form 36 (SF-36). When the two groups were compared, the noCOPD group had a slightly higher median FTND and Richmond test scores, though the differences were not statistically significant (p=0.537 and p=0.449, respectively). The COPD group showed lower values for all evaluated parameters (p≤0.008), but no difference was detected between the groups regarding IOS. SAD was present in 74% of COPD group participants and 73% of noCOPD group participants, with no statistically significant difference (p=0.934, Cramer's V=0.01). Participants with COPD took longer to complete the TGlittre tasks (p=0.011). There were no significant differences between the groups on the FACIT-F scale (p=0.964) or the SF-36, except for the "physical functioning" domain, which was worse in the COPD group (p=0.018). In conclusion, individuals seeking CBT exhibit a high degree of nicotine dependence, regardless of COPD status. SAD is detected in approximately three-quarters of these individuals, regardless of COPD status. Furthermore, low FEC is more common in people with COPD, though general fatigue and QoL are impaired in smokers with and without COPD.

Downloads

Download data is not yet available.

Hashimoto R, Tomioka H, Wada T, Yoshizumi Y. Outcomes and predictive factors for successful smoking cessation therapy in COPD patients with nicotine dependence. Respir Investig 2020;58:387-94. DOI: https://doi.org/10.1016/j.resinv.2020.03.007

Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: 2026 report. Accessed from: https://goldcopd.org/2026-gold-report/.

Benowitz NL. Pharmacology of nicotine: addiction, smoking induced disease, and therapeutics. Annu Rev Pharmacol Toxicol 2009;49:57-71. DOI: https://doi.org/10.1146/annurev.pharmtox.48.113006.094742

Jiménez-Ruiz CA, Andreas S, Lewis KE, et al. Statement on smoking cessation in COPD and other pulmonary diseases and in smokers with comorbidities who find it difficult to quit. Eur Respir J 2015;46:61-79. DOI: https://doi.org/10.1183/09031936.00092614

Liu Y, Greenlund KJ, VanFrank B, et al. Smoking cessation among U.S. Adult smokers with and without chronic obstructive pulmonary disease, 2018. Am J Prev Med 2022;62:492-502. DOI: https://doi.org/10.1016/j.amepre.2021.12.001

Papadopoulou E, Haidich A-B, Mathioudakis A, et al. The Fagerström Test for Nicotine Dependence, as a prognostic factor, in current smokers with and without COPD: A cross-sectional study in northern Greece. Chron Respir Dis 2024;21:14799731241235213. DOI: https://doi.org/10.1177/14799731241235213

Jiménez-Ruiz CA, Miravitlles M, Sobradillo V, et al. Can cumulative tobacco consumption, FTND score, and carbon monoxide concentrations in expired air be predictors of chronic obstructive pulmonary disease? Nicotine Tob Res 2004;6:649-53. DOI: https://doi.org/10.1080/14622200410001727948

Ben Moussa S, Rouatbi S, Ben Saad H. Incapacity, handicap, and oxidative stress markers of male smokers with and without COPD. Respir Care 2016;61:668-79. DOI: https://doi.org/10.4187/respcare.04420

Su Z-Q, Guan W-J, Li S-W, et al. Significances of spirometry and impulse oscillometry for detecting small airway disorders assessed with endobronchial optical coherence tomography in COPD. Int J Chron Obstruct Pulmon Dis 2018:13:3031-44. DOI: https://doi.org/10.2147/COPD.S172639

Lu L, Tang G, Wan Q, et al. Long-term variability of impulse oscillometry defined small airway dysfunction in participants with and without chronic obstructive pulmonary disease. BMJ Open Respir Res 2026;13:e003918. DOI: https://doi.org/10.1136/bmjresp-2025-003918

Bazzan E, Semenzato U, Turato G, et al. Symptomatic smokers without COPD have physiological changes heralding the development of COPD. ERJ Open Res 2022;8:00202-2022. DOI: https://doi.org/10.1183/23120541.00202-2022

King GG, Bates J, Berger KI, et al. Technical standards for respiratory oscillometry. Eur Respir J 2020;55:1900753. DOI: https://doi.org/10.1183/13993003.00753-2019

Pisi R, Aiello M, Frizzelli A, et al. Detection of small airway dysfunction in asymptomatic smokers with preserved spirometry: the value of the impulse oscillometry system. Int J Chron Obstruct Pulmon Dis 2021:16:2585-90. DOI: https://doi.org/10.2147/COPD.S319972

Manning K, Zvolensky MJ, Gallagher MW, et al. Understanding fatigue severity and smoking deprivation in smoking behavior and urges: a pilot test. Exp Clin Psychopharmacol 2025;33:285-90. DOI: https://doi.org/10.1037/pha0000773

Wang Z, Qiu Y, Ji X, Dong L. Effects of smoking cessation on individuals with COPD: a systematic review and meta-analysis. Front Public Health 2024:12:1433269. DOI: https://doi.org/10.3389/fpubh.2024.1433269

Da Costa CCM, Olímpio Júnior H, Da Silva Pinto PVL, et al. Contribution of small airway disease to dynamic hyperinflation in patients with chronic obstructive pulmonary disease. Monaldi Arch Chest Dis 2026;96:3402. DOI: https://doi.org/10.4081/monaldi.2025.3402

Skumlien S, Hagelund T, Bjørtuft O, Ryg MS. A field test of functional status as performance of activities of daily living in COPD patients. Respir Med 2006;100:316-23. DOI: https://doi.org/10.1016/j.rmed.2005.04.022

Casara A, Turato G, Marin-Oto M, et al. Chronic bronchitis affects outcomes in smokers without chronic obstructive pulmonary disease (COPD). J Clin Med 2022;11:4886. DOI: https://doi.org/10.3390/jcm11164886

Cui Y, Forget EL, Torabi M, et al. Health-related quality of life and economic burden to smoking behaviour among Canadians. Can J Public Health 2019;110:533-41. DOI: https://doi.org/10.17269/s41997-019-00244-x

Garcia-Rio F, Miravitlles M, Soriano JB, et al. Prevalence of reduced lung diffusing capacity and CT scan findings in smokers without airflow limitation: a population-based study.BMJ Open Respir Res 2023;10:e001468. DOI: https://doi.org/10.1136/bmjresp-2022-001468

Reis CMD, Karloh M, Fonseca FR, et al. Functional capacity measurement: reference equations for the Glittre Activities of Daily Living test. J Bras Pneumol 2018;44:370-7. DOI: https://doi.org/10.1590/s1806-37562017000000118

Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict 1991;86:1119-1127. DOI: https://doi.org/10.1111/j.1360-0443.1991.tb01879.x

Meneses-Gaya IC, Zuardi AW, Loureiro SR, Crippa JA. Psychometric properties of the Fagerström Test for Nicotine Dependence. J Bras Pneumol 2009;35:73-82. DOI: https://doi.org/10.1590/S1806-37132009000100011

Richmond RL, Kehoe LA, Webster IW. Multivariate models for predicting abstention following intervention to stop smoking by general practitioners. Addiction 1993;88:1127-35. DOI: https://doi.org/10.1111/j.1360-0443.1993.tb02132.x

Ciconelli RM, Ferraz MB, Santos W., Meinão I, et al. Brazilian-Portuguese version of the SF-36. A reliable and valid quality of life outcome measure. Rev Bras Reumatol 1999;39:143-50.

Brazier JE, Harper R, Jones NM, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 1992;305:160-4. DOI: https://doi.org/10.1136/bmj.305.6846.160

Mosher CE, Duhamel KN. An examination of distress, sleep, and fatigue in metastatic breast cancer patients. Psychooncology 2012;21:100-7. DOI: https://doi.org/10.1002/pon.1873

Acaster S, Dickerhoof R, DeBusk K, et al. Qualitative and quantitative validation of the FACIT-fatigue scale in iron deficiency anemia. Health Qual Life Outcomes 2015;13:60. DOI: https://doi.org/10.1186/s12955-015-0257-x

Graham BL, Steenbruggen I, Miller MR, et al. Standardization of spirometry 2019 update. An official American Thoracic Society and European Respiratory Society technical statement. Am J Respir Crit Care Med 2019;200:e70-88. DOI: https://doi.org/10.1164/rccm.201908-1590ST

Pereira CAC, Sato T, Rodrigues SC. New reference values for forced spirometry in white adults in Brazil. J Bras Pneumol 2007;33:397-406. DOI: https://doi.org/10.1590/S1806-37132007000400008

Butzko RP, Sotolongo AM, Helmer DA, et al. Forced oscillation technique in veterans with preserved spirometry and chronic respiratory symptoms. Respir Physiol Neurobiol 2019;260:8-16. DOI: https://doi.org/10.1016/j.resp.2018.11.012

Chaiwong W, Namwongprom S, Liwsrisakun C, Pothirat C. Diagnostic ability of impulse oscillometry in diagnosis of chronic obstructive pulmonary disease. COPD 2020;17:635-46. DOI: https://doi.org/10.1080/15412555.2020.1839042

Kim DK, Hersh CP, Washko GR, et al. Epidemiology, radiology, and genetics of nicotine dependence in COPD. Respir Res 2011;12:9. DOI: https://doi.org/10.1186/1465-9921-12-9

Li J, Liu, L, Tang J, et al. Small airway disease in pre-COPD and early COPD: insights into the pulmonary "silent zone". Int J Chron Obstruct Pulmon Dis 2026;21:604789. DOI: https://doi.org/10.2147/COPD.S604789

Obeid S, Akel M, Haddad C, et al. Factors associated with alcohol use disorder: the role of depression, anxiety, stress, alexithymia and work fatigue- a population study in Lebanon. BMC Public Health 2020;20:245. DOI: https://doi.org/10.1186/s12889-020-8345-1

Matthews JA, Sallis HM, Dyer ML, et al. Associations between self-reported sleep quality, fatigue severity, factors associated with successful cessation, and cessation beliefs among regular smokers. Nicotine Tob Res 2024;26:835-42. DOI: https://doi.org/10.1093/ntr/ntad231

Agustí A, Calverley PM, Celli B, et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 2010;11:122. DOI: https://doi.org/10.1186/1465-9921-11-122

Ethics Approval

The study was approved by the Research Ethics Committee of the Augusto Motta University Centre, Rio de Janeiro, Brazil, under protocol number CAAE-90474125.3.0000.5235. The protocol was registered with ClinicalTrials.gov under the reference number NCT07186049.

How to Cite



Pinto, Jorge Marcelo Titiry, Iasmim Maria Pereira Pinto Fonseca, Juliana Pessanha de Freitas, Barbara Moreira Canabrava, Danielle Pires Gomes de Souza, Jhonny França Valverde de Souza, Sylvia Freitas Ferreira, Patrícia Frascari Litrento, Cristiane Almeida Pires Tourinho, and Agnaldo José Lopes. 2026. “Nicotine Dependence and Physical Function: A Comparison Between Current Smokers With and Without Chronic Obstructive Pulmonary Disease Who Seek Cognitive-Behavioral Therapy”. Monaldi Archives for Chest Disease, October. https://doi.org/10.4081/monaldi.2026.4388.